Skip to main content

Darlene Walley, Ph.D.

CEO, NEXT Life Sciences

Dr. Walley is the CEO of NEXT Life Sciences, a Reproductive Health platform company with two male birth control products in clinical trials, Plan ATM and PausePill™
Dr. Walley has over 30 years of Life Science business experience, having served as Executive at Procter & Gamble, Gillette/Oral-B Laboratories and Arm & Hammer and CEO of early-stage Pharma/Biotech companies. Darlene is very skilled in the launch of products/companies, raising capital and improving performance. Darlene works with start-up companies, investment firms and serves on the Board of Directors of several companies.
Dr. Walley has launched over 100 products – OTC, Rx and Medical Devices. She has raised over $100M with 5 successful exits totaling over $1B.
She holds 12 patents, largely dealing with consumer health products, and over 13 publications.
Dr. Walley received a BA in Chemistry from Case Western Reserve University and a PhD in Organic Chemistry from the UC.